luspatercept-aamt 75 MG Injection

RxCUI: 2262913
RxNorm name: luspatercept-aamt 75 MG Injection
Display name: luspatercept-aamt 75 MG Injection
Full name: luspatercept-aamt 75 MG Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:06

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761136	Reblozyl	luspatercept-aamt	351(a)	Rx	2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Reblozyl	LUSPATERCEPT	Celgene Corporation	82f4d266-3f52-41eb-86ba-0abf3cf468e8	2026-02-27	Warnings, Adverse reactions	Exact identifier rxcui: 2262913

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
82f4d266-3f52-41eb-86ba-0abf3cf468e8	luspatercept-aamt 75 MG Injection [PSN] · luspatercept-aamt 75 MG Injection [SCD]	2	20	These highlights do not include all the information needed to use REBLOZYL safely and effectively. See full prescribing information for REBLOZYL. REBLOZYL ® (luspatercept-aamt) for injection, for subcutaneous use Initial U.S. Approval: 2019	20260227